T1	Disorder 16 41	interstitial lung disease
N1 	Reference T1 UMLS:C0206062	interstitial lung disease
T2	Pharmacological_substance 48 57	erlotinib
N1000 	Reference T2 MeSH:D000069347	erlotinib
T3	Disorder 91 109	radiation fibrosis
T4	Pharmacological_substance 135 144	gefitinib
N1001 	Reference T4 MeSH:C419708	gefitinib
T5	Disorder 171 197	non-small-cell lung cancer
N2 	Reference T5 UMLS:C0007131	non-small-cell lung cancer
T6	Disorder 223 248	interstitial lung disease
N3 	Reference T6 UMLS:C0206062	interstitial lung disease
T7	Disorder 250 253	ILD
N4 	Reference T7 UMLS:C0206062	ILD
T8	Pharmacological_substance 276 285	erlotinib
N1002 	Reference T8 MeSH:D000069347	erlotinib
T9	Disorder 294 297	ILD
N5 	Reference T9 UMLS:C0206062	ILD
T10	Disorder 381 414	idiopathic interstitial pneumonia
N6 	Reference T10 UMLS:C2350236	idiopathic interstitial pneumonia
T11	Disorder 420 423	ILD
N7 	Reference T11 UMLS:C0206062	ILD
T12	Disorder 442 460	radiation fibrosis
T13	Pharmacological_substance 571 580	erlotinib
N1003 	Reference T13 MeSH:D000069347	erlotinib
T14	Disorder 589 592	ILD
N8 	Reference T14 UMLS:C0206062	ILD
T15	Disorder 680 698	radiation fibrosis
T16	Pharmacological_substance 742 751	erlotinib
N1004 	Reference T16 MeSH:D000069347	erlotinib
T17	Pharmacological_substance 804 813	erlotinib
N1005 	Reference T17 MeSH:D000069347	erlotinib
T18	Disorder 977 980	ILD
N9 	Reference T18 UMLS:C0206062	ILD
T19	Pharmacological_substance 1018 1027	erlotinib
N1006 	Reference T19 MeSH:D000069347	erlotinib
T20	Disorder 1036 1039	ILD
N10 	Reference T20 UMLS:C0206062	ILD
T21	Disorder 1061 1080	respiratory failure
N11 	Reference T21 UMLS:C1145670	respiratory failure
T22	Pharmacological_substance 1118 1127	erlotinib
N1007 	Reference T22 MeSH:D000069347	erlotinib
T23	Pharmacological_substance 1195 1204	erlotinib
N1008 	Reference T23 MeSH:D000069347	erlotinib
T24	Disorder 1220 1238	radiation fibrosis
T25	Disorder 1259 1277	radiation fibrosis
T26	Disorder 1326 1329	ILD
N12 	Reference T26 UMLS:C0206062	ILD
T27	Pharmacological_substance 1349 1358	erlotinib
N1009 	Reference T27 MeSH:D000069347	erlotinib
T28	Subject 78 85	patient
T34	Subject 429 436	patient
T37	Disorder 373 377	ILDs
N13 	Reference T37 UMLS:C0206062	ILDs
T39	Subject 667 674	patient
T40	Subject 702 726	50-year-old male patient
T43	Pharmacological_substance 1097 1104	steroid
N1010 	Reference T43 MeSH:D013256	steroid
T35	Coreferring_mention 350 364	these two drug
T44	Disorder 841 884	rapid progression of reticular infiltration
N14 	Reference T44 UMLS:C0150312	rapid progression of reticular infiltration
T48	Subject 1333 1341	patients
T52	Coreferring_mention 1045 1052	patient
